Head of CRC, Clinical Oncologist and Deputy Head of Department of Radiotherapy and Oncology, IKN

Email: florencefui@yahoo.com  

MCO (UM), MBBS (UM)

Areas of interest: Lung cancer, Hepatobiliary cancer, Genitourinary cancer, Head and neck cancer, Neuroendocrine cancer

Awards and achievements:

• Top Recruiter for RAINBOW and PARACHUTE Trials, 2018
• Clinical Trial Site of the Year, 2018
• Lead Trainer for Master of Clinical Oncology Program in IKN
• Member of Specialty Subcommittee for Education (SSC-Edu) for Clinical Oncology, Medical Education Committee (MEC), Majlis Perubatan Malaysia (MPM)
• External Reviewer for Traditional and Complementary Medicine Practice Guideline on Herbal Therapy as Adjunct Treatment for Cancer Edition 2, 2018
• Member of Clinical Practice Guideline for Nasopharyngeal Carcinoma (Malaysia) Development Group, 2017
• Expert Committee for the Effect of Chinese Herbal Medicine as an Adjunct Management of Fatigue and Muscle Weakness in Cancer Patients Receiving Chemotherapy under Health Technology Assessment, 2017

Dr. Wong Yoke Fui is a distinguished clinical oncologist with over a decade of experience in the field. She currently serves as the Deputy Head of the Radiotherapy and Oncology Department at Institut Kanser Negara (IKN) and has led the Clinical Research Centre (CRC) IKN since 2016. Dr. Wong earned her MBBS degree from Universiti Malaya in 2005 and completed her Master of Clinical Oncology at the same institution in 2014. She is also the Lead Trainer for the Master in Clinical Oncology program at IKN. Since joining IKN in 2014, Dr. Wong has been actively engaged in both Industry Sponsored Research (ISR) and Investigator Initiated Research (IIR), alongside her clinical duties. Her research primarily focuses on solid tumours, with a special interest in head and neck cancers and neuroendocrine tumours. Over the past eight years, Dr. Wong has significantly contributed to oncology trials, serving as Principal Investigator in 22 clinical trials and as Sub-Investigator in an additional 10 trials across various cancer types. Her exceptional dedication to advancing cancer research and improving patient outcomes has earned her the respect and admiration of both colleagues and patients

Multicentre Clinical Epidemiological Study of Female Breast Cancer in a Multi-ethnic Malaysian Setting (Epi-Can)

Epi-Can is a multicentre retrospective cohort study that involves seven of the Ministry of Health (MOH) hospitals in Malaysia. This study aimed to determine the nature of breast cancer patients’ presentation, diagnosis, management of treatment, treatment-induced cardiovascular complications and survival while describing the variation across age, socioeconomic, geographic regions, ethnic differences and its trend over time in Malaysia. The results of this study will aid in observing secular changes as well as long-term outcomes for breast cancer patients in real-world clinical practice.

Treatment and Decision Making Among Breast Cancer Patient in Malaysia

Effect Of Herbal Medicine For Xerostomia In Head And Neck Cancer Patients: An Observational Study In A Tertiary Cancer Hospital

Prospective Observational Study on Pazopanib in Patients Treated for Advanced Or Metastatic Renal Cell Carcinoma (RCC) in Asia, North Africa and Middle East Countries: Final Analysis of PARACHUTE Study